CCEL logo

Cryo-Cell International, Inc. Stock Price

NYSEAM:CCEL Community·US$34.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

CCEL Share Price Performance

US$4.04
-5.29 (-56.70%)
US$4.04
-5.29 (-56.70%)
Price US$4.04

CCEL Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slight risk and fair value.

4 Risks
1 Reward

Cryo-Cell International, Inc. Key Details

US$31.7m

Revenue

US$7.3m

Cost of Revenue

US$24.5m

Gross Profit

US$24.9m

Other Expenses

-US$473.6k

Earnings

Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
n/a
-0.059
77.07%
-1.49%
-78.1%
View Full Analysis

About CCEL

Founded
1989
Employees
84
CEO
David Portnoy
WebsiteView website
www.cryo-cell.com

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Recent CCEL News & Updates

Recent updates

No updates